[Treatment of chronic polyarthritis with Sulindac].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001597:Benzylidene Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007192:Indenes / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos
D000893:Anti-Inflammatory Agents; D001597:Benzylidene Compounds; D007192:Indenes; D010919:Placebos; D007052:Ibuprofen
Die Behandlung der chronischen Polyarthritis mit Sulindac.